Centessa Pharmaceuticals PLC
F:260
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Centessa Pharmaceuticals PLC
F:260
|
UK |
|
L
|
LY Corp
DUS:YOJ
|
JP |
|
I
|
Indocement Tunggal Prakarsa Tbk PT
XBER:ITP
|
ID |
|
K
|
Karnalyte Resources Inc
OTC:KRLTF
|
CA |
|
Newmark Group Inc
F:NMB
|
US |
|
K
|
Koninklijke Philips NV
DUS:PHIA
|
NL |
|
Advanced Micro Devices Inc
NASDAQ:AMD
|
US |
|
PLC SpA
F:O29
|
IT |
|
F
|
Fielmann Group AG
DUS:FIE
|
DE |
|
C
|
CECO Environmental Corp
F:WCE
|
US |
|
L
|
LVMH Moet Hennessy Louis Vuitton SE
DUS:MOH
|
FR |
|
A
|
Allstate Corp
XMUN:ALS
|
US |
|
FirstGroup PLC
LSE:FGP
|
UK |
|
U
|
United Parcel Service Inc
BMV:UPS
|
US |
|
A
|
Air Lease Corp
F:AVLA
|
US |
|
F
|
FirstGroup PLC
F:FGR
|
UK |
|
A
|
AdCapital AG
DUS:ADC
|
DE |
|
Gentili Mosconi SpA
F:Z5A
|
IT |
|
O
|
Overstock.com Inc
F:OVER
|
US |
|
L
|
Lenzing AG
XMUN:LEN
|
AT |
|
Toppan Inc
OTC:TONPF
|
JP |
|
Royal Bank of Canada
TSX:RY
|
CA |
|
DBS Group Holdings Ltd
F:DEVL
|
SG |
|
C
|
Citigroup Inc
DUS:TRVC
|
US |
Bankruptcy Probability
Centessa Pharmaceuticals PLC's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Centessa Pharmaceuticals PLC Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| UK |
|
Centessa Pharmaceuticals PLC
NASDAQ:CNTA
|
6.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Takara Bio Inc
TSE:4974
|
120.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
461.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
202B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
163B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
134.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
69.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
51.4B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Centessa Pharmaceuticals PLC's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Centessa Pharmaceuticals PLC has total debt of 110.1m USD. This includes both short-term (0 USD) and long-term (110.1m USD) debt.
You can find a full breakdown on its Balance Sheet.
